Dune Medical Devices, Inc. announced that positive interim results from a European post-market study of the MarginProbe? System, a technology to enable better detection and removal of cancerous tissue during breast-conserving surgery (BCS), were presented at the German Breast Cancer Society Meeting (DGS 2010) held in Hamburg, Germany from July 1-3, 2010...
More...